» Articles » PMID: 37484564

Synthesis and Pharmacological Evaluation of 1,3-diaryl Substituted Pyrazole Based (thio)urea Derivatives As Potent Antimicrobial Agents Against Multi-drug Resistant and

Abstract

The urgent development of newer alternatives has been deemed a panacea for tackling emerging antimicrobial resistance effectively. Herein, we report the design, synthesis, and biological evaluation of 1,3-diaryl substituted pyrazole-based urea and thiourea derivatives as antimicrobial agents. Preliminary screening results revealed that compound 7a (3,4-dichlorophenyl derivative) exhibited potent activity against (MIC = 0.25 μg mL) and compound 7j (2,4-difluorophenyl derivative) against (MIC = 1 μg mL). Compounds 7a and 7j were non-toxic to Vero cells with a favorable selectivity index of 40 and 200, respectively, and demonstrated good microsomal stability. Compound 7a exhibited equipotent activity (MIC = 0.25 μg mL) against various multidrug-resistant strains of , which include various strains of MRSA and VRSA, and elicited bacteriostatic properties. In an enzymatic assay, 7a effectively inhibited DNA gyrase supercoiling activity at a concentration of 8 times MIC. Further, molecular modeling studies suggested that compound 7a binds at the active site of DNA gyrase with good affinity.

Citing Articles

Design, synthesis, and biological evaluation of pyrazole-ciprofloxacin hybrids as antibacterial and antibiofilm agents against .

Ommi O, Dhopat P, Sau S, Estharla M, Nanduri S, Kalia N RSC Med Chem. 2024; .

PMID: 39493222 PMC: 11528910. DOI: 10.1039/d4md00623b.


On-demand imidazolidinyl urea-based tissue-like, self-healable, and antibacterial hydrogels for infectious wound care.

Wu Q, Ghosal K, Kanaan N, Roy S, Rashed N, Majumder R Bioact Mater. 2024; 44:116-130.

PMID: 39484021 PMC: 11525126. DOI: 10.1016/j.bioactmat.2024.10.003.


New Pyrazolyl Thioureas Active against the Genus.

Schito A, Caviglia D, Penco S, Spallarossa A, Cichero E, Tasso B Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543162 PMC: 10974609. DOI: 10.3390/ph17030376.

References
1.
Loomba P, Taneja J, Mishra B . Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients. J Glob Infect Dis. 2010; 2(3):275-83. PMC: 2946685. DOI: 10.4103/0974-777X.68535. View

2.
Arora G, Gagandeep , Behura A, Gosain T, Shaliwal R, Kidwai S . NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular by Induction of Autophagy. Front Microbiol. 2020; 10:3051. PMC: 6999026. DOI: 10.3389/fmicb.2019.03051. View

3.
Han S, Sang Y, Wu Y, Tao Y, Pannecouque C, De Clercq E . Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. ACS Infect Dis. 2019; 6(5):787-801. DOI: 10.1021/acsinfecdis.9b00229. View

4.
Yang T, Chen G, Sang Z, Liu Y, Yang X, Chang Y . Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies. J Med Chem. 2015; 58(16):6389-409. DOI: 10.1021/acs.jmedchem.5b00152. View

5.
Huang A, Wo K, Lee S, Kneitschel N, Chang J, Zhu K . Regioselective Synthesis, NMR, and Crystallographic Analysis of N1-Substituted Pyrazoles. J Org Chem. 2017; 82(17):8864-8872. DOI: 10.1021/acs.joc.7b01006. View